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Twenty-five cyclic nucleotide analogs were tested 
individually to  act as lipolytic agents  and to activate 
adipocyte protein kinase. The lipolytic potency of in- 
dividual analogs correlated  better  with  their K,  for 
protein kinase  and  their lipophilicity rather than  with 
either  parameter alone. Some of the most potent lipo- 
lytic analogs had high Iao values for  the  particulate low 
K ,  cAMP phosphodiesterase suggesting that their  ef- 
fect was not due to raising endogenous cAMP levels 
through inhibition of phosphodiesterase. The most  po- 
tent lipolytic analogs contained a thio moiety at the C- 
8 or C-6 position. These analogs exhibited concave 
upward dose-response curves. At high concentrations, 
some analogs were as effective as optimal concentra- 
tions of epinephrine  in  stimulating lycerol release. 
The regulatory subunit of protein kinase has two 
different intrachain CAMP-binding sites and cAMP 
analogs modified at  the C-8 position (C-8 analogs) are 
generally selective for  Site 1 and analogs modified at 
the C-6 position (C-6 analogs) are generally selective 
for  Site  2 (Rannels, S .  R., and Corbin, J. D. (1980) J. 
Biol. Chem. 255,7085-7088). Thus, C-8 and C-6 an- 
alogs were tested in combination to stimulate lipolysis 
in  intact adipocytes and  to  activate protein kinase in 
vitro. Each process was stimulated synergistically by 
a combination of a C-6 and C-8 analog. Two C-8 ana- 
logs or two C-6 analogs added together did not cause 
synergism of either process. For both lipolysis and 
protein kinase  activation, C-8 thio analogs acted more 
synergistically than C-8 amino analogs when incu- 
bated in combination with C-6 analogs, a characteristic 
of type I1 protein kinase. It is concluded that  the ob- 
served synergism of lipolysis is due to binding of  cAMP 
analogs to both intrachain  sites  and  that  it s the  type 
I1 protein kinase isozyme which is responsible for  the 
lipolytic response. 
The CAMP-dependent protein kinase mediates most, if not 
all, of the effects of cAMP in mammalian tissues (1, 2). Of 
present  interest is the regulation of lipolysis in adipocytes via 
the hormone-sensitive lipase. The only established mecha- 
nism of regulation of the lipase is CAMP-dependent phospho- 
rylation-activation (3-5) and M$+-requiring dephosphoryla- 
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tion-inactivation (6). The CAMP-dependent protein kinase is 
usually present in tissues as  a mixture of type I  and type I1 
isozymes (7, 8). By several criteria, the rat adipose tissue 
protein kinase appears to be primarily a type I1  isozyme but 
it may not be identical with the type I1 kinase from rat cardiac 
tissue (9) and  it has  not been determined which isozyme is 
ultimately responsible for the lipolytic response. 
It has been established that both type I and type I1 isozymes 
are composed of two monomeric catalytic subunits and an 
inhibitory, dimeric regulatory subunit containing two CAMP- 
binding sites per monomeric chain (10). These intrachain 
CAMP-binding sites can be differentiated based on their 
cAMP dissociation rates  (11,12)  and cAMP analog specificity 
(12). Site 1 is characterized by a slower dissociation rate  and 
has  a relative selectivity for cAMP analogs modified at the  C- 
8 position on  the adenine ring (C-8 analogs) while Site 2 has 
a faster dissociation rate and is more selective for analogs 
modified at  the C-6 position (C-6 analogs). [3H]cIMP (Site 2 
selective) and 8-a~ido-[~~P]cAMP (Site 1 selective) binding 
experiments established that binding of cyclic nucleotides at 
either  site  stimulates binding at the  other  site for both type I 
and type I1 protein kinase isozymes  (13, 14). Further,  it was 
demonstrated for both isozymes that a synergism of protein 
kinase activation occurs using a combination of Site 1 and 
Site 2 selective analogs (15). For Site l-selective analogs, a 
nitrogen atom attached at C-8 is optimally synergistic with 
C-6 analogs when using type I while a sulfur atom  attachment 
is most effective using type I1 (15). 
In  the present studies, we extend these in vitro findings to 
demonstrate a synergism of the CAMP-mediated lipolytic 
response in isolated intact adipocytes. In addition, we expand 
previous cyclic nucleotide structure-activity studies to corre- 
late analog effects on  protein kinase activation and lipolysis, 
and explore the factors responsible for the lipolytic efficacy 
of the analogs. By adding analog combinations to intact 
tissues, novel approaches can be made to delineate cellular 
cyclic nucleotide effector control mechanisms. First, a new 
test  is available to establish whether or not  the  protein kinase 
is the mediator of a particular response. Second, the particular 
isozyme or isozyme mixture responsible for the effect in 
tissues can potentially be identified. Third, because cyclic 
nucleotide binding to Sites 1 and 2 is cooperative, an estima- 
tion  can be made of the magnitude of the sensitivity magni- 
fication at  the protein kinase step in the  intact tissue. Last, 
since analog combinations are synergistic, this allows  for the 
use of lower total analog concentration to obtain the same 
cellular response as would  be obtained using a single analog. 
EXPERIMENTAL PROCEDURES 
Preparation of Adipocytes and  Cell Incubations-Adipocytes were 
isolated by collagenase treatment according to  the method of Rodbell 
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3540 Synergism of cAMP Analogs 
(161, from epididymal fat pads of 130-200-g Sprague-Dawley rats. 
Epididymal fat was incubated in KRBA' containing 1 mM  CaC12, 
3.5%  bovine serum albumin (fraction V). The cells were  washed and 
suspended in  the same buffer such that  the  fat dry weight was 35-55 
mg/ml  cell suspension. Incubations were carried out  in closed  poly- 
propylene vials,  gassed  with 95% 0 2  and 5% COa in the presence or 
absence of various concentrations of cyclic nucleotide analogs or 
other lipolytic agents. When  IBMX was present, the concentration 
was 200 p ~ .  Incubations were routinely done in a shaking water bath 
(64 cycles/min) at 20 "C. The synergism of lipolysis was quantitated 
using a synergism quotient which is defined as the ratio of the 
observed level of glycerol release when C-6 and C-8 analogs are 
incubated in combination to  the expected level of glycerol release 
determined from the sum of the effects of each individual analog. 
Glycerol Determination-At various times, aliquots of incubation 
mixture were made 3% perchloric acid and  then 13%  (v/v) carbon 
tetrachloride. The samples were mixed and spun  in a desk-top clinical 
centrifuge for 5-10 min. After KOH neutralization, aliquots of the 
supernatants were  removed and assayed for glycerol according to  the 
method of Wieland (17). Lipolysis is expressed as micromoles of 
glycerol/g of fat. The fat dry weight was determined by spotting 
aliquots of incubation mixtures on nitrocellulose papers, drying, and 
weighing. 
Determination of Partition Coefficients-The partition coefficients 
of various cyclic nucleotide analogs were determined using 1-butanol 
as  the organic phase and 0.05 M potassium phosphate (pH 7.4) as  the 
aqueous phase. The two phases were first mixed and allowed to 
separate overnight, and  the resulting phases were  used to determine 
the partition coefficients. 3 ml of 1-butanol were added to 1 ml of 
cyclic nucleotide analog (50 pM) diluted in 0.05 M potassium phos- 
phate and vigorously mixed for 30 s on a Vortex-Genie (Fisher 
Scientific) at a setting of 4. The samples were spun  in a desk-top 
clinical centrifuge to speed the phase  separation. The absorbance of 
the analog in potassium phosphate was determined at 260 nm before 
and after 1-butanol extraction. The difference in absorbance was 
taken  as that fraction of analog which partitioned into  the 1-butanol. 
The  partition coefficient was determined by the ratio of the concen- 
tration of analog in the 1-butanol to  the concentration in potassium 
phosphate after organic extraction. The analogs partitioned less 
effectively into tert-amyl alcohol but followed the same rank order as 
with 1-butanol. 
Protein Kinase Assay-The activity of the CAMP-dependent pro- 
tein kinase was determined using a modification of the filter paper 
assay procedure described by Roskoski (181, using the synthetic 
heptapeptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly) as substrate. The re- 
action mixture contained 50 mM Tris (pH 7.5), 2% glycerol, 1 mM 
EGTA, 43 mM 2-mercaptoethanol, 65 PM synthetic peptide, 200 PM 
[Y-~*P]ATP (100-200 cpm/pmol), 10 mM MgC12 in the presence or 
absence of 5 IM CAMP. When IBMX was present, the concentration 
was 200 p ~ .  The reaction was terminated  after 5 min of incubation 
at 30  "C. The reaction was linear  in the presence or absence of cAMP 
for a t  least 10 min. The CAMP-dependent protein kinase activity 
ratio is defined as  the ratio of activity measured in the absence and 
presence of 5 IM CAMP. 
K. Determination for Cyclic Nwleotides-The K, for cAMP and 
cyclic nucleotide analogs was determined in the standard protein 
kinase assay in the presence of  200 PM IBMX. The  data were fitted 
to  the Hill equation after  subtraction of basal activity ratios which 
were between 0.02 and 0.13. The cyclic nucleotide concentrations 
were varied between 3 and 10,000 nM. Protein kinase was present at 
0.5-1.0 nM regulatory subunit monomer for the DEAE-cellulose con- 
centrated enzyme or 0.05-0.1 nM after  separation by sucrose density 
gradient centrifugation. The K, for cAMP was unaffected by pH 
values between 6.8 and 8.0 or the presence or absence of sucrose 
(2.5%), glycerol (2%), or IBMX (200 pM). 
Preparation of Adipocyte Particulate Phosphodiesterase-The low 
K,,, phosphodiesterase was prepared by modification of the method of 
Loten et al. (19). Adipocytes from four rat epididymal fat pads were 
prepared as described above. Cells were washed two times with KRBA 
and  three additional times with 10 mM Tris-HCI, 1 mM EDTA (pH 
7.5) containing 250 mM sucrose (TSE buffer). Cells were resuspended 
in 5 ml of TSE buffer and homogenized with 10 strokes of the A 
pestle using a Dounce homogenizer. The homogenate was centrifuged 
for 30 min at 20,000 rpm and  the supernatant was discarded. The 
The abbreviations used are: KRBA, Krebs-Ringer bicarbonate 
buffer; IBMX, 3-isobutyl-1-methylxanthine; EGTA, ethylene glycol- 
bis(p-aminoethyl ether)-N,N,N',N'-tetraacetic acid. 
pellet was washed by gentle resuspension in 5 ml of TSE buffer 
followed by centrifugation. The resulting pellet was resuspended in 
5-10  ml  of 10 mM Tris-HCI, 1 mM EDTA (pH 7.5) using 10 strokes 
of the pestle and centrifuged at 20,000 rpm, and the supernatant 
fraction was assayed for low K ,  phosphodiesterase activity. 
cyclic nucleotide phosphodiesterase activity was measured as de- 
scribed by Loten et al.  (19). In all experiments, enzyme  was added in 
a concentration which resulted in the hydrolysis of approximately 
25% of the substrate. [SH]cAMP was  always present at a concentra- 
tion of  0.1 pM and cyclic nucleotide analogs were added to the reaction 
in a wide range of concentrations. Their ability to compete for 
CAMP hydrolysis is expressed as the concentration of analog which 
inhibited cAMP hydrolysis by 50% (Iw). 
Isolation of CAMP-dependent Protein Kinase-The  CAMP-depend- 
ent protein kinase was partially purified from adipocytes using 
DEAE-cellulose according to the method of Corbin et al. (9). Adipo- 
cytes were prepared as described above. After two washes with KRBA, 
adipocytes were washed twice with 10 mM potassium phosphate, 1 
mM EDTA, and 250 mM sucrose (pH 6.8) (buffer A) and suspended 
in the same buffer except with 10 mM EDTA (buffer B). The adipo- 
cytes were hand-homogenized with 20 strokes of the B pestle using a 
Dounce  homogenizer. The homogenate was centrifuged for 30 min at 
20,000 X g. One main peak of protein kinase activity eluted from 
DEAE-cellulose at  170 mM NaCl as previously shown for adipose 
tissue (8). 
Materials-Bovine serum albumin was purchased from Reheis 
Chemical Co.  Collagenase  was obtained from Worthington Diagnostic 
Systems, Inc. Glycerol kinase, glycerol-3-phosphate dehydrogenase 
and N6-phenylisopropyladenosine were products of Boehringer Man- 
nheim. 2'-5'-Dideoxyadenosine was obtained from P-L Biochemicals, 
Inc. 8-Thioisopropyl-CAMP and 8-thiobenzyl-CAMP were received 
from ICN. 8-Aminobutylamino-CAMP was synthesized as previously 
described (14). The following analogs were generously provided by 
Drs. Jon Miller and Robert Suva of the Biomedical Research Labo- 
ratory, Life Sciences Division, SRI International, Menlo Park, C A  
N6-carbamoylpropyl-CAMP, 6-thiomethyl-cNMP,  M-hydroxy- 
CAMP, 8-thio-pNOzbenzyl-cAMP,  8-hydroxy-cAMP, 8-amino- 
ethanol-CAMP, 2-trifluoromethyl-cAMP, and 2-aminodimethyl- 
CAMP. All other cyclic nucleotide analogs were purchased from 
Sigma. 
RESULTS 
Effect of Cyclic Nucleotide Analog Concentration on Glycerol 
Release-A variety of cyclic nucleotide analogs at  various 
concentration were tested for their lipolytic effects on adipo- 
cytes. Adipocyte incubations with analogs or hormones were 
carried out at  20 "C. When  experiments were done at  37 "C, 
similar dose-response or time-response characteristics were 
seen except the time-response curves were shifted to  the left. 
Fig. 1 shows the dose-response curves of 16 representative 
analogs. The studies in Fig. 1 and Table I were carried out by 
measuring glycerol release after 60 min of incubation with 
each individual analog at  several concentrations. Duplicate 
glycerol determinations were done on each of two or more 
adipocyte preparations. Generally, the various analogs fit into 
three major catagories based on  their dose-response charac- 
teristics. The effects of N6-benzoyl- and 8-bromo-CAMP were 
relatively linear with concentration (Fig. IC). Analogs which 
were modified with alkyl chains at  the C-6 positions (N6-Bt 
and N6-AHCM,  Fig. 1, D and B, respectively), a hydroxyl at 
the C-6 or C-8 position (N6-hydroxy- and 8-hydroxy-CAMP, 
Fig. 1B) or amine-containing substituents at  the C-8 position 
(8-aminomethyl- and 8-aminobenzyl-cAMP, Fig. 1A) had hy- 
perbolic dose-response curves. Concave-upward dose-re- 
sponse curves were characteristic for analogs containing a 
thio derivative (8-thiomethyl-CAMP, 8-thiobenzyl-cAMP, 
Fig. 1A and 6-thiomethyl-cNMP, Fig. 1B). 
Table I shows values for glycerol release of 23 cyclic nu- 
cleotide analogs tested as lipolytic agents. The analogs are 
listed according to decreasing efficacy for a modification of a 
given position on the adenine ring. The values for glycerol 
release (nanomoles/g/pM analog/h) were determined from 
linear regressions of dose-response curves from experiments 
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FIG. 1. The effect of cyclic nucleotide analog concentration 
on lipolysis. Lipolysis was determined by measuring glycerol release 
after 1 h of incubation at 20 "C. The plotted values have been 
corrected for glycerol released in the absence of added cyclic nucleo- 
tide analogs. N6-Bt, N6-butyryl; N6-AHCM, N6-aminohexylcarba- 
moylpropyl. 
like those shown in Fig. 1. Since most of the analogs had 
nonlinear dose-response characteristics, the order of Table  I 
represents an average concentration effect. It follows that  the 
order was mainly determined by the highest concentration of 
analog tested (910 p ~ ) .  N6-Carbamoylpropyl- and  N6-ben- 
z o y l - c ~ ~ ~  were the most effective lipolytic agents tested. 
Analogs  modified with a  thio moiety at  the C-6 or C-8 position 
were also very potent. On the  other  hand, analogs containing 
amino derivatives at  the C-8 position were relatively poor at 
stimulating lipolysis. cIMP, cGMP, 8-bromo-cGMP, 2-tri- 
fluoromethyl-CAMP, 2-aminodimethyl-CAMP, and CAMP it- 
self were poor lipolytic agents. When analogs were ordered 
based on their effects at lower concentrations (90 pM), a 
similar order of efficacy  was obtained except N'-hydroxy- and 
8-hydroxy-CAMP were the most potent  and  8-thiomethyl-, 8- 
thioisopropyl-, and 8-thiobenzyl-CAMP had  a somewhat lower 
rank. However, C-8 analogs with thio modifications were 
always better lipolytic agents than analogs containing amino 
substituents. 
Several factors were considered to be responsible for the 
efficacy of the analogs tested in these studies. An analog 
should be an effective lipolytic agent if it 1) has a good 
lipophilic character so that  it can  pass through the plasma 
membrane and  enter  the cell, 2) is an effective activator of 
CAMP-dependent protein kinase which subsequently phos- 
phorylates and  activates the hormone-sensitive lipase, and 3) 
is not hydrolyzed  by the phosphodiesterases present in the 
cell. Therefore, we attempted to measure parameters of the 
analogs which  would  be predictive of their ability to stimulate 
glycerol  release. As a measure of lipophilicity, the  partition 
coefficients of several analogs were determined. Several ana- 
logs  were also tested for their ability to activate the type I1 
CAMP-dependent protein kinase. Since few  of these analogs 
were available with radioactive labels, it was difficult to di- 
rectly study the hydrolysis of these derivatives. Alternatively, 
we studied the ability of some analogs to inhibit [3H]cAMP 
hydrolysis by the low K,,, phosphodiesterase isolated from the 
adipocyte high speed pellet. Table I1 shows the values for 
glycerol release taken from Table I with the partition coeffi- 
cient, K, for protein kinase activation and  the I, for the low 
K,,, CAMP-phosphodiesterase. 
Analogs with hydrophobic substituents such as alkyl and 
TABLE I 
Effect of cyclic nucleotides on glycerol  release 
Cyclic nucleotide analogs are listed in order from the most to  the least potent for a given modification on the 
purine ring. The average analog concentration effect was determined from linear regression analysis of dose- 
response curves like those indicated in Fig. 2. Glycerol release was determined as described under "Experimental 
Procedures" and is expressed as nanomoles of glycerol/g of fat, dry weight/pM  of analog/h. 
Cyclic nucleotide analog 
Abbreviated name Substituent 
Glycerol release 
nmnf/duM/h 
C-6 analog 
C-8 analog 
C-2 analog 
cGMP analog 
cAMP 
Ne-Carbamoylpropyl 
Ne-Benzoyl 
6-Thiomethyl nebularine 
N'-Hydroxy 
Ne-Aminohexylcarbamoylmethyl 
Ne-Butyryl 
NB-CONH-C&i, 
6-S-CHa-cNMP 
NB-OH 
N'-(CHZ)e-NH-CONH-CHS 
P-COz-CaH, 
NB-CO*-C& 
cIMP 
8-Thio-pNOzbenzyl 
8-Thiomethyl 
8-Thioisopropyl 
8-Thiobenzyl 
8-Amino 
8-Bromo 
8-Amiiohexylamino 
8-Aminobenzyl 
8-Aminomethyl 
8-Aminoethanol 
2-Aminodimethyl 
2-Trifluoromethyl 
8-Bromo 
cGMP 
8-Hydroxy 
8-S-pNOz-CHz-C&, 
8-S-CHs 
8-S-isoCaH, 
8-OH 
8-S-CHZ-C&is 
8-NH2 
S-NH-(CHz)e-NHz 
8-NH-CHZ-Ca 
8-NH-CHa 
8-NH-CH&-OH 
2-CFs 
2-N-(CH& 
8-Br 
8-Br-cGMP 
0.23 
7.86 
4.07 
7.54 
2.66 
0.93 
0.83 
0.01 
5.71 
5.68 
4.73 
4.39 
2.04 
1.63 
1.07 
1.05 
0.25 
0.43 
0.16 
0.0 
0.0 
0.0 
0.11 
. -. r 
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3542 Synergism of cAMP Analogs 
TABLE I1
Various parameters of CAMP analogs 
Values for glycerol release were taken from Table I. The partition coefficient, K,, for protein kinase activation 
and  the Im for the low K ,  phosphodiesterase were determined as described under "Experimental Procedures." 
Cyclic AMP analog 
NO-Carbamoylpropyl 
Ns-Benzoyl 
8-Thiomethyl 
8-Thioisopropyl 
8-Thiobenzyl 
%Amino 
8-Bromo 
N6-Butyryl 
8-Aminomethyl 
8-Aminobenzyl 
cAMP 
2-Trifluoromethyl 
cIMP 
Glycerol 
release 
nm&?/&M 
anulogjh 
7.9 
7.5 
5.7 
4.7 
4.4 
1.6 
1.1 
0.9 
0.4 
0.3 
0.2 
0.0 
0.0 
coefficient 
Partition 
4.9 
3.0 
1.6 
6.6 
19.4 
0.4 
1.6 
1.3 
0.9 
10.9 
0.6 
4.6 
0.2 
~~ 
Protein kinase Phosphodies- 
activation 
(KJ 
terase 
I W  
&M P M  
1.9 492 
2.1 90 
0.3  46 
0.5 60 
0.6 48 
0.2 40 
0.2 14 
3.0  597 
0.6 33 
4.0 202 
0.2 0.06 
1.6 0.005 
6.9 0.60 
aryl groups had high partition coefficients while analogs with 
more hydrophilic substituents such as 8-amino derivatives, 
cIMP, and cAMP had low partition coefficients. There was 
no clear correlation between the  partition coefficient of the 
analog and its ability to stimulate glycerol  release.  Likewise, 
there was no clear correlation between the K ,  of the analog 
for protein kinase activation and its ability to serve as  an 
effective lipolytic agent. In addition, there appeared to be no 
correlation between the lipolytic effectiveness of an analog 
and its ability to inhibit the low K,,, phosphodiesterase as 
indicated by  150 values. The I60 values in  Table I1 indicate that 
good lipolytic analogs required high concentrations to  inhibit 
[3H]cAMP hydrolysis. When the partition coefficient, the K, 
for protein kinase activation, and the Im for the phosphodi- 
esterase were all considered, the lipolytic effectiveness of the 
analogs was explained (Table 11). 
Comparison of Effects of Epinephrine and Cyclic AMP  An- 
alogs on  Lipolysis-Fig. 2 shows the effect of time on epineph- 
rine and cAMP analog-stimulated glycerol release. Because 
linear regression was  used to determine the  rates of glycerol 
release  when  possible, all of the lines do not necessarily pass 
through 0. Fig. 2 shows that 10 PM epinephrine in  the presence 
of 200 )LM IBMX resulted in a linear rate of 127 nmol of 
glycerol/g of fat/min for at least 90 min. When IBMX was 
deleted from the incubation media, the  rate of lipolysis  was 
decreased by approximately 15-20%. The presence of high 
concentrations of N'-benzoyl-cAMP (455 pM) and 8-bromo- 
cAMP (1364 PM) did not  alter the rate of epinephrine-induced 
lipolysis. When 455 p~ N6-benzoyl- and 1364 p~ 8-bromo- 
cAMP were incubated with adipocytes in the absence of 
hormone, a concave-upward time course was seen. The rate 
of lipolysis  was 75 nmol of glycerol/g of fat/min in the first 
30 min of incubation in this experiment but 130 nmol of 
glycerol/g of fat/min in last 30 min. When the concentrations 
of N6-benzoyl- and 8-bromo-CAMP were reduced (136 and 
455 PM, respectively) and the incubation time was extended, 
a more pronounced concave-upward time course was evident. 
Millimolar concentrations of N6-benzoyl-, Ebthiomethyl-, 
8-thiobenzyl-, 8-thio-pN02benzyl-,  and N6-carbamoylpropyl- 
cAMP stimulated lipolysis at rates approximately equal to 
epinephrine (not shown). Concave-upward time courses  were 
generally seen with all analogs which  were  effective lipolytic 
agents. Since the concave-upward time-effect relationship was 
I4'O t + 12.0 - 
0 
.c 
c 
," 10.0- 
In - 
E" - a 8.0-  
a 
a z 6.0- 
0, 
0 - 
- 
- 2 4.0 - 
W 
20 40 60 80 1 0 0  120 140 I 
'"t 0 0 /' 
0 
Time (Minufec) 
FIG. 2. The effect of epinephrine and CAMP analogs on 
lipolysis. Adipocytes were incubated in the presence of 10 p~ epi- 
nephrine alone (O), 10 phi epinephrine, and 200 phi IBMX (m), 10 
pM epinephrine with 455 pM p-benzoyl- and 1364 pM 8-bromo- 
cAMP (e), 455 phi W-benzoyl- and 1364 NM 8-bromo-CAMP (A), 
and 136 SM N'-benzoyl- and 455 p~ 8-bromo-CAMP (V). Glycerol 
release was determined as a measure of lipolysis at  the indicated 
times. 
still seen when the adipocytes were preincubated for 60 min 
before the addition of the analogs, it appears that  the concave- 
upward time courses  were not due to the generation of cyclic 
nucleotide-independent factor(s) during the experiment (data 
not shown). The shape of these concave-upward time courses 
was unaffected by adenosine (100 p ~ ) ,  phenylisopropyladen- 
osine (0.1 and 10 p ~ ) ,  2',5'-dideoxyadenosine (50 p ~ ) ,  or
IBMX (200 p ~ ) ,  suggesting that  the adenosine receptors are 
not sites of action of analogs or other factors generated during 
the incubation which account for the concave-upward time 
courses (20, 21). Since IBMX antagonizes the inhibitory 
adenosine receptor of the adipocyte  (22) as well as inhlbks 
the phosphodiesterase, these data also suggest that under 
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these conditions these processes play only a minor role in 
analog-stimualted lipolysis. 
Effect of Analog Combinations on Glycerol Release-Pre- 
vious studies from this laboratory have demonstrated that 
binding of a CAMP analog selective for either  intrachain  site 
on the regulatory subunit of protein kinase stimulated binding 
of a cAMP analog selective for the other site (13, 14). A 
continuation of these studies demonstrated that two such 
site-selective analogs could also be used in combination to 
synergistically activate protein kinase (15). The main ap- 
proach of the present studies was to determine if these in 
uitro findings could be extended to isolated, intact cell prep- 
arations  to  demonstrate a synergism of a metabolic response 
believed to be mediated by protein kinase. Consequently, 
isolated adipocytes were incubated in the presence of site- 
selective cAMP analogs alone and  in combination and glycerol 
release was determined as a measure of lipolysis. The first 
series of experiments of this type were carried out with the 
Site 1-selective analog 8-bromo-CAMP and the  Site 2-selective 
analog N'-benzoyl-CAMP. The first approach was to carry 
out time courses with increasing concentrations of a fixed 
ratio of these analogs (Fig. 3). The basal, unstimulated rate 
of glycerol  release varied in  this series of experiments from 
essentially 0 (Fig. 3A) to 9 nmol/g of fat/min (Fig. 3B). This 
control level of lipolysis was always subtracted from the 
experimental values to obtain a net value for glycerol  release. 
To quantitate the resulting effects on glycerol release, a 
synergism quotient was used. The synergism quotient was 
defined as  the net effect of the analog combination on lipolysis 
divided by the sum of the  net individual analog effects on 
lipolysis. A quotient greater than 1 indicated a synergistic 
effect while a quotient less than 1 indicated that  an inhibitory 
effect on lipolysis occurred. For experiments using N'-ben- 
zoyl-CAMP and 8-bromo-CAMP, the synergism quotients were 
generally not higher than 2.5 when the absolute net values at 
any given time point were  considered. At intermediate con- 
centrations of this analog pair, synergism quotients varied 
from less than or equal to 1.0 after  short periods of incubation 
(15-30 min) to values of around 2.0 after longer incubation 
periods (Fig. 3B). At higher concentrations of analog and 
particularly after longer periods of incubation, synergism 
quotients were higher (Fig. 3, C and D). When time-effect 
relationships were linear, synergism quotients were calculated 
using linear regression analysis. The synergism quotients were 
1.35 and 2.0 in Fig. 3, A and B, respectively.  However,  when 
time-effect relationships were not linear (Fig. 3, C and D), 
calculation of the synergism quotient based on absolute net 
glycerol  values at any given point of determination may  give 
conservative estimations of the magnitude of synergism. Since 
under these conditions the rate of lipolysis was changing, it 
may  be appropriate to consider the relative rates of glycerol 
release  between time points. In Fig. 3C, the  rate of lipolysis 
with each analog alone was linear while the  rate of lipolysis 
when both analogs were present was concave upward. The 
synergism quotients calculated after 60 and 90 min of incu- 
bation were 1.2 and 1.8,  respectively. If, however, the relative 
rates between 30 and 60 min or 60 and 120  min  were consid- 
ered, the synergism quotients were 1.8 and 3.3, respectively. 
However, the apparent disparity between the values calcu- 
lated by these two approaches was reduced as the rate of 
lipolysis  due to a single analog varied with time as occurred 
with higher concentrations of  N'-benzoyl-CAMP (Fig. 3 0 ) .  
Another approach to investigating the effects of cAMP 
analog combinations on lipolysis was to keep one analog at a 
constant concentration while the concentration of the other 
analog was varied. Fig. 4 shows one experiment of this type 
in which the  Site 2-selective analog N'-benzoyl-cAMP and 
the  Site 1-selective analog 8-thioisopropyl-CAMP were incu- 
bated alone and  in combination. In Fig. 4A, glycerol  release 
was measured after adipocytes were incubated for 2 h with 10 
FIG. 3. The effect of increasing 
concentrations of a fixed ratio of 
P-benzoyl- and  8-bromo-CAMP on 
synergism of lipolysis. N6-Benzoyl- 
(0) and 8-bromo-CAMP (A) were incu- 
bated alone and in combination (0) at  a 
fixed ratio of about 3. Each part repre- 
sents a different adipocyte preparation. 
The values at  each time point represent 
glycerol determinations on duplicate in- 
cubations. Lipolysis was measured by 
glycerol release. 
Time ( Minutes) 
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FIG. 4. Synergistic effect of W-benzoyl- and 8-thioisopropyl-CAMP on lipolysis. N'-Benzoyl-CAMP 
(10 phi) and  8-thioisopropyl-CAMP (100 p ~ )  were incubated  alone  and  in the presence of various  concentrations 
of the  other  analog  and  glycerol  release  was  determined  after 2 h of incubation.  The striped  portion of the bars 
represent  glycerol  values for 10 FM Ng-benzoyl-CAMP (A)  and 100 pM 8-thioisopropyl-CAMP ( B )  when  incubated 
alone. The open  portion of the bars represent  glycerol  values  for  increasing  concentrations of b-thioisopropyl- 
cAMP (A)  and N'-benzoyl-cAMP ( B )  when incubated alone. The height of the bars on the kft of each pair 
represents  the sum of the  individual  analog  effects or the  expected  glycerol  value if analogs were incubated  together. 
The total height of the solid bar indicates  the  observed  glycerol value when  analogs were incubated  in  combination 
at the  indicated  concentrations.  The  differences  between  the  heights of the paired bars reflects the magnitude of 
synergism of lipolysis.  The  data  represent  means  and  standard  errors of triplicate  determinations  in a representative 
experiment.  The insets show the synergism  quotient at each  concentration of analog  combination.  The  synergism 
quotient is defined under  "Experimental  Procedures." WBZL,  N'-benzoyl-CAMP; d-S-isoP, 8-thioisopropyl-CAMP. 
p~ N6-benzoyl-CAMP and various concentrations of 8-thioi- 
sopropyl-CAMP and Fig. 5B shows the reverse approach  in 
which  100 p~ 8-thioisopropyl-CAMP was combined with var- 
ious concentrations of N'-benzoyl-cAMP. The bar on the left 
of each pair indicates the sum of the analog effects on lipolysis 
while the bar on the right of each pair indicates the observed 
lipolytic effects of the analog when combined in  the incuba- 
tion media. The insets show the synergism quotients which 
were based on the ratios of the heights of these bars. 10 p~ 
N'-benzoyl-cAMP and 100 p~ 8-thioisopropyl-CAMP were 
approximately equipotent as lipolytic agents (striped bars, 
Fig.  4, A and B, respectively). When N6-benzoyl-CAMP (10- 
100 p ~ )  and 8-thioisopropyl-CAMP (30-300 p ~ )  were incu- 
bated alone, linear dose-response data were seen (open bars, 
Fig. 4). At higher concentrations (1000 p ~ ) ,  8-thioisopropyl- 
CAMP, unlike N'-benzoyl, demonstrated concave-upward 
dose-response characteristics typical of the 8-thio-CAMP an- 
alogs (Fig. 1). 
When 10 p~ N'-benzoyl-cAMP was incubated with con- 
centrations of 8-thioisopropyl-CAMP which alone were in  a 
region of linear dose-response effects (30, 100, and 300 pM), 
a relatively constant degree of synergism was seen (Fig. 4A, 
inset). The  apparent maximum synergism quotient of about 
1.5 was not increased when a lower  (10 p ~ )  or higher (1000 
p ~ )  concentration of 8-thioisopropyl-CAMP was incubated  in 
combination with N'-benzoyl-cAMP. It is not surprising that 
synergism was not seen at  the highest concentration of 8- 
thioisopropyl-CAMP tested since this analog concentration 
alone elicited a maximal lipolytic response. The magnitude of 
synergism seen with this experimental approach was not 
dependent on the concentration of 8-thioisopropyl-CAMP. 
However, when 8-thioisopropyl-CAMP was kept constant  and 
the concentration of N6-benzoyl-CAMP  was varied, the syn- 
ergism quotient was directly proportional to  the concentration 
of N'-benzoyl-cAMP (Fig. 4B, inset). In these experiments, 
the synergism quotient varied between 1.1 and 2.4 as the 
concentration of N6-benzoyl-CAMP was increased from 3 to 
100 p ~ .  As the concentration of N6-benzoyl-CAMP was in- 
creased to yield a maximal lipolytic effect, the synergism 
quotient again approached 1.0 (data  not shown). N6-Benzoyl- 
cAMP also had a dose-dependent synergistic effect on epi- 
nephrine-stimulated (3,25, and 200  nM) and IBMX (200 p ~ ) -  
stimulated lipolysis (data  not shown). At  very low concentra- 
tions of N'-benzoyl-cAMP (1 p ~ ) ,  an inhibition of 8-thioi- 
sopropyl-CAMP-stimulated lipolysis was seen (synergism quo- 
tient = 0.65). When detailed time courses (such as those  in 
Fig. 3) were carried out, synergism quotients of less than 1 
were sometimes seen. When this inhibition of glycerol release 
was present, it was seen when at least one analog was present 
at  low concentrations and/or at early time  points when the 
concentration of the analog at its active site(s) would be 
expected to be low. N'-Benzoyl-cAMP, the most thoroughly 
studied analog, frequently showed this characteristic. 
Experiments similar to those  in Fig. 4 carried out with N6- 
benzoyl-CAMP and  the  Site 1-selective analog 8-bromo-CAMP 
produced similar results. A relatively constant synergism quo- 
tient of about 2.0 was seen when incubations were carried out 
when the concentration of 8-Br-CAMP was varied in the 
presence of a constant concentration of N'-benzoyl-cAMP 
between 15 and 90 p~ 8-bromo-CAMP. An increasing mag- 
nitude of synergism was obtained when the concentration of 
N'-benzoyl-cAMP was increased from 10 to 140 p~ in the 
presence of 30 p~ 8-bromo-CAMP. 
Synergism of lipolysis with cAMP analog combinations was 
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FIG. 5. Comparison of synergism of lipolysis and synergism 
of adipocyte type TI protein kinase activation using C-6 and 
C-8 cAMP analogs. A, synergism of lipolysis was determined by 
incubating adipocytes with C-6 analogs and C-8 analogs alone and in 
combination and measuring glycerol released after 2 h of incubation. 
The striped bars show the effects of N6-benzoyl-CAMP (left) and  Ne- 
carbamoylpropyl-CAMP (right) when incubated alone. The unshoded 
bars on the left of each pair of bars show the effects of the indicated 
C-8 analog when incubated alone. The  total height of the bar on the 
right of each pair indicates the effects on glycerol release when the 
indicated C-8 analogs were incubated with adipocytes in the presence 
of N'-benzoyl-cAMP (left) or N6-carbamoylpropyl-CAMP (right). The 
shaded portion of the bar indicates the extent of synergism. The data 
represent the means and  standard errors of four to eight determina- 
tions on each of two different adipocyte preparations. B, synergism 
of protein kinase activation was determined by incubating adipocyte 
type I1 protein kinase with C-6 analogs and C-8 analogs alone and in 
combination in the  standard protein kinase assay. The activity ratios 
represent the increases above basal due to  the indicated concentra- 
tions of the various analogs. The basal activity ratio determined in 
the absence and  the presence of 5 p~ cAMP was 0.09. The protein 
kinase was isolated by DEAE-cellulose chromatography. The data 
indicate the means and  standard errors of three or four determina- 
tions. N'BZL, N'-benzoyl-cAMP; Ne-CONH-P, N6-carbamoylpro- 
pyl-CAMP; 8-AHA, 8-aminohexylamino-CAMP 8-ABA, 8-aminobu- 
tylamino-CAMP; 8-S-is0 CJI,, 8-thioisopropyl-CAMP; 8-S-CH3, 8- 
thiomethyl-CAMP. 
seen when the sum of the lipolytic effects of the individual 
analogs was  between 10 and 50% of the optimally stimulated 
level of glycerol  release as determined by 10 ~ L M  epinephrine 
in the presence of  200 WM IBMX. Synergism of lipolysis  was 
only seen when a  Site 1-selective analog was incubated with 
a  Site 2-selective analog but not when  two Site 1-selective or 
two Site 2-selective analogs were  combined (Table 111). When 
two  C-6 analogs or two C-8 analogs were  combined such that 
TABLE 111 
Lack of synergism of glycerol release with pairs of C-6 or pairs 
Of C-8 analogs 
Combination divided 
Analog combination by s u m  of individual effecta (synergism 
quotient) 
N6-Carbamoylpropyl (91 p ~ )  + N6-benzoyl 0.86 
N6-Carbamoylpropyl (91 pM) + N6-butyryl 0.86 
W-Benzoyl(45 pM) + N6-butyryl (91 pM) 0.94 
8-Thiobenzyl (91 phf) + 8-aminomethyl (91 cM) 0.98 
8-Thiobenzyl (91 @M) + 8-methyl (91 pM) 1.02 
8-Aminomethyl (91 p M )  + 8-methyl (91 pM) 0.72 
8-Thiobenzyl (91 pM) + 8-bromo (91 pM) 1.04 
(45 PM) 
(91 I ~ M )  
alone they stimulated lipolysis  10-20% each, their synergism 
quotients were less than  or equal to 1. 
This laboratory had previously shown that bovine heart 
type I1 and  rat  heart type I protein kinase exhibited a different 
C-8 analog specificity for stimulation of binding and syner- 
gism  of activation when incubated with a C-6 analog (14,151. 
Specifically, when used in combination with C-6 analogs, 
those analogs with a sulfur atom attached  to C-8 acted more 
synergistically using type 11 protein kinase and type I exhib- 
ited greater synergism using analogs with a nitrogen atom 
attached at  C-8. Consequently, the use of 8-thio- and 8-amino- 
cAMP analogs in combination with  C-6  analogs  could poten- 
tially differentiate between a type I1 and a type I protein 
kinase-mediated metabolic response. When adipocyte protein 
kinase was isolated on DEAE-cellulose, it eluted at a salt 
concentration consistent with a type I1 protein kinase. It was 
therefore of interest  to see if the site-specific analog pattern 
of synergism of lipolysis  could  be correlated with synergism 
of adipocyte type I1 protein kinase. Fig. 5A shows the lipolytic 
effects of individual analogs and the sum of their effects such 
that they can be compared with the effects of various analog 
combinations. In Fig. 5A, the  total height of the bar on the 
right of each pair indicates the amount of glycerol  released 
when the adipocytes are incubated with the analog combina- 
tions. The shaded portion of the bars indicates the  extent of 
synergism. The observed levels of glycerol release varied 
among the combinations depending on whether the C-6 analog 
was incubated with a C-8-thio analog or a C-8-amino analog. 
Incubation of N6-carbamoylpropyl-CAMP  or N6-benzoyl- 
CAMP with either 8-thio-CAMP  analog  produced the greatest 
degree of glycerol release over that expected  from the sum of 
the individual analogs alone (synergism quotients = 2.5-3.6). 
Both of the C-6 analogs acted far more synergistically when 
incubated in combination with 8-thio-CAMP analogs than 
when incubated with 8-amino derivatives. Only a limited 
degree of synergism was expressed when either C-6 analog 
was incubated in combination with the 8-aminohexylamino- 
or 8-aminobutylamino-CAMP (average  synergism quotient = 
1.2). Similar results were achieved with these C-6  analogs in 
combination with 8-aminobenzyl-CAMP (not shown). 
These  data for lipolytic effects are in excellent agreement 
with studies using the same analogs on activation of isolated 
adipocyte type I1 protein kinase (Fig. 5B). The basal protein 
kinase activity ratio, determined in the absence of added  cyclic 
nucleotides, varied between 0.08 and 0.13. In each experiment, 
the basal activity ratio was subtracted  to give the change in 
activity ratio due to  the analogs being tested. The order of 
effectiveness of the analog pairs for synergism of protein 
kinase activation follows the same order of effectiveness  for 
glycerol  release. Both N'-benzoyl-cAMP and N'-carbamoyl- 
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3546 Synergism of cAMP Analogs 
propyl-CAMP acted most synergistically with 8-thioisopropyl- 
and 8-thiomethyl-CAMP. The C-6 analogs were much less 
effective in combination with 8-aminohexylamino- and 8- 
aminobutylamino-CAMP. Although the increases in activity 
ratio due to the individual analogs alone were small, the 
magnitude of change due to  the 8-thio derivatives were greater 
than that due to the 8-amino derivatives. However, other 
studies on activation of adipocyte protein kinase indicated 
that increasing the effect on activity ratio by increasing the 
concentration of 8-amino derivatives or decreasing the effect 
by decreasing the concentrations of 8-thio derivatives had no 
bearing on their order of effectiveness for synergism when 
incubated in combination with C-6 analogs. These studies 
also indicated that synergism of adipocyte protein kinase 
could be readily demonstrated as long as the sum of the 
individual analog effects on the activity ratio did not exceed 
about 50% of the maximal activity ratio change. This is in 
agreement with previous studies on the synergism of activa- 
tion of rat  heart type I and bovine heart type I1 protein kinase 
(15). 
It had previously  been  shown that 8-thio-CAMP was con- 
siderably better  in combination with C-6 analogs for binding 
to  and activation of type I1 than for type I protein kinase (14, 
15). However, in results not shown, 8-thio-CAMP was rela- 
tively poor  when tested for lipolysis with these C-6 analogs 
although 8-thio-CAMP acted more synergistically with N6- 
carbamoylpropyl- than with N'-benzoyl-cAMP. The inability 
of 8-thio-CAMP to show strong synergism in combination 
with (2-6 analogs in the isolated adipocyte system or in the 
adipocyte protein kinase activation studies is not totally 
understood but may  suggest differences in the type I1 kinases 
from heart  and adipose tissue. Differences in these enzymes 
have already been  suggested (9). 
Other studies comparing synergism of glycerol  release and 
synergism of protein kinase activation were also carried out 
using N6-butyryl-, N6-carbamoylpropyl-, and N6-benzoyl- 
cAMP in combination with the Site 1-selective analog 8- 
aminomethyl-CAMP and the Site 2-selective analog 8-thio- 
benzyl-CAMP. The combination of 8-aminomethyl-CAMP 
with each of the C-6 analogs did not produce synergism of 
lipolysis. However, 8-thiobenzyl-CAMP produced synergism 
quotients between 3.2 and 3.6 when incubated in combination 
with C-6 analogs. These  data were consistent with the exper- 
iments carried out measuring protein kinase activity ratios. 
In each case, the synergism  produced  with the C-6 analog in 
combination with 8-thiobenzyl-CAMP was  1.5-1.7 times 
greater than when C-6 analogs were paired with 8-aminome- 
thyl-CAMP. Again, the overall correlation of lipolysis and 
protein kinase activation in these experiments is unmistaka- 
ble. 
DISCUSSION 
The activation of protein kinase by cAMP is a critical step 
in the process of hormone-stimulated cascade amplification. 
Koshland et al. (23) have defined two  forms of signal ampli- 
fication. Magnitude amplification is characterized by the pro- 
duction of a large number of output molecules (e.g. free fatty 
acids released from adipose tissue) generated by a small 
number of stimulus molecules (e.g. hormone). Sensitivity am- 
plification, on the  other hand, is characterized by a greater 
percentage change in response than expected  from the per- 
centage change in stimulus. Studies presented here support 
other work (12-15) and provide proof that protein kinase 
activation is an important  step  in sensitivity amplification. 
Briefly, it has been established that  the positive cooperativity 
in cyclic nucleotide binding is reflected by cooperativity in 
protein kinase activation (15). In the present studies, the 
synergistic activation of protein kinase is well correlated with 
a synergistic lipolytic response when isolated protein kinase 
or adipocytes are incubated in the presence of a combination 
of a  Site 1-selective and  a  Site 2-selective  cAMP  analog. 
Data presented here not only demonstrate that  the protein 
kinase is the mediator of the cyclic  nucleotide analog syner- 
gistic effect on lipolysis, but also suggest that  it is the type I1 
isozyme  which is responsible  for the lipolytic  effect. For both 
protein kinase activation and lipolysis, the synergism was 
greater when a C-6 analog was incubated in combination with 
a C-&thio analog than when incubated with a C-&amino 
analog, a type I1 protein kinase response (15). Furthermore, 
the pattern of selective synergism of lipolysis was closely 
correlated with the same pattern of synergism of type I1 
protein kinase activation. 
The efficacy of analogs as protein kinase agonists in intact 
cells or in  intact organisms is dependent upon the concentra- 
tion of analog at its site of action. The lipolytic  efficacy of all 
the analogs tested appears to be explained by consideration 
of at least two  of three basic analog properties: high lipophil- 
icity, low K,, for protein kinase activation, and stability to low 
K ,  phosphodiesterase hydrolysis. For example,  some of the 
most  effective lipolytic agents generally  have  relatively  high 
KO values for protein kinase activation, but have favorable 
partition coefficients and  are relatively resistant to  the phos- 
phodiesterase. On the other hand, relatively  ineffective  lipo- 
lytic agents have lower K,, values but tend  to have  unfavorable 
partition coefficients and  are less resistant to  the phosphodi- 
esterase. Analogs  which  have either excessively  high or low 
partition coefficients are not so effective  lipolytic agents as 
might be  expected  from their K,  values. This could  be  due to 
their inability to cross the cell membrane in  the case of a low 
partition coefficient  or the inability to  partition out of the 
membrane or the lipid droplet in the case of a high partition 
coefficient.  Although these conclusions seem sound, we have 
not presently ruled out that some  analogs  may  be  metabolized 
by a mechanism other than the phosphodiesterase(s) to a 
more  effective  or a less effective  lipolytic agent. 
The strong correlation between  synergism of lipolysis and 
synergism of protein kinase activation, in addition to the 
synergism of binding (14, 15) and type I1 protein kinase 
activaton previously demonstrated (15), leaves little doubt 
that protein kinase, and  not any other mechanism, is repon- 
sible  for the synergistic effect of analogs on lipolysis.  However, 
a discussion of other possible mechanisms is presented. The 
presently available data argue against phosphodiesterase. The 
analog specificity of the high K ,  phosphodiesterase has not 
been studied but the effects of cAMP  analogs  on the low K ,  
phosphodiesterase, which is believed to play a major  role in 
the hydrolysis of intracellualr cAMP (19, 24), have been 
investigated. It is difficult to explain the synergism  based on 
analog effects on this enzyme. Although the synergism of 
lipolysis and protein kinase activation occur  over a wide range 
of concentrations, this synergism is readily seen at low analog 
concentrations, almost certainly below concentrations re- 
quired for phosphodiesterase inhibition. In addition, since the 
best lipolytic agents, N6-carbamoylpropyl- and N'-benzoyl- 
CAMP, have IW values 492 and 45 times higher than their KO 
values, it seems highly unlikely that  the phosphodiesterase 
would significantly contribute to  the analog-stimulated lipol- 
ysis.  Some of the  data presented here also  argue against a role 
for the adenosine receptor in the synergism of lipolysis. Fain 
and Malbon (25) have demonstrated that adipose tissue is 
normally under tonic adenosine inhibition, causing adenylate 
cyclase and lipolysis to be less responsive to hormone stimu- 
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lation. The experiments here were carried out at relatively 
high adipocyte concentrations where adenosine inhibition of 
adenylate cyclase was essentially complete. This conclusion 
was supported since analog-stimulated lipolysis  was not in- 
hibited by N6-phenylisopropyladenosine; therefore, under 
these conditions, endogenous cAMP formation was minimal 
and  the likelihood of endogenously generated cAMP  due to 
an adenosine receptor mechanism was  remote. It is possible, 
however, that if the adenylate cyclase inhibition were  released 
by some adenosine antagonist which could be generated or 
introduced as  a  contaminant of the analog preparation the 
endogenous cAMP levels  could increase. This does not appear 
to be the mechanism of the synergism of lipolysis  since IBMX, 
an adenosine receptor antagonist (26), does not prevent the 
lipolytic synergism due to N6-benzoyl- and 8-bromo-CAMP 
(data  not shown). 
There are several possible explanations for the concave- 
upward dose-response effects of analogs on lipolysis. One 
possibility is that low concentrations of the analog activate 
one protein kinase isozyme and higher concentrations activate 
the  other type. This seems unlikely in view of the  fact that 
type I is very low, or absent,  in the adipocyte. It has not been 
totally ruled out that high concentrations of these analogs 
inhibit either the phosphodiesterase or the adenosine receptor 
and endogenous cAMP contributes to the concave-upward 
dose-response curves. 
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